Preliminary results of the "Sovet" observational program for use of natalizumab in the treatment of patients with remitting multiple sclerosis

Authors
Category Primary study
JournalNeuroscience and Behavioral Physiology
Year 2014
This article has no abstract
Epistemonikos ID: baea21db5339dcdbda0f418e7a5f39e730ef229e
First added on: Feb 06, 2025